Prostate Cancer - Results from #25900

A contemporary update on pathology reporting for prostate cancer: Biopsy and radical prostatectomy specimens - Abstract May 15, 2012

Classifying prostate cancer malignancy by quantitative histomorphometry - Abstract May 15, 2012

International variation in prostate cancer incidence and mortality rates - Abstract May 15, 2012

Introducing parametric fusion PET/MRI of primary prostate cancer - Abstract May 15, 2012

Prediction of functional outcomes after nerve-sparing radical prostatectomy: Results of conditional survival analyses - Abstract May 15, 2012

Salvage cryoablation for locally recurrent prostate cancer following primary radiotherapy - Abstract May 15, 2012

Racial/Ethnic differences in treatment discussed, preferred, and received for prostate cancer in a tri-ethnic population - Abstract May 14, 2012

Is sampling transitional zone in patients who had prior negative prostate biopsy necessary? - Abstract May 14, 2012

Pathological findings at radical prostatectomy in patients initially managed by active surveillance: A comparative analysis - Abstract May 14, 2012

Lymph node count threshold for optimal pelvic lymph node staging in prostate cancer - Abstract May 14, 2012

The needs of carers of men with prostate cancer and barriers and enablers to meeting them: A qualitative study in England - Abstract May 14, 2012

When serial prostate biopsy is recommended: Most cancers detected are clinically insignificant - Abstract May 14, 2012

Do patient-reported androgen-deprivation therapy side effects predict anxiety and depression among prostate cancer patients undergoing radiotherapy? Implications for psychosocial therapy interventions - Abstract May 14, 2012

Comparison of distribution- and anchor-based approaches to infer changes in health-related quality of life of prostate cancer survivors - Abstract May 14, 2012

The influence of antidiabetic medications on the development and progression of prostate cancer - Abstract May 14, 2012

Value of PET/CT and MR lymphography in treatment of prostate cancer patients with lymph node metastases - Abstract May 14, 2012

Interactions of abiraterone, eplerenone, and prednisolone with wild-type and mutant androgen receptor: A rationale for increasing abiraterone exposure or combining with MDV3100 - Abstract May 11, 2012

Effects of robotic-assisted laparoscopic prostatectomy on surgical pathology specimens - Abstract May 11, 2012

Nuclear factor κB predicts poor outcome in patients with hormone-naive prostate cancer with high nuclear androgen receptor - Abstract May 11, 2012

Microscopic assessment of fresh prostate tumour specimens yields significantly increased rates of correctly annotated samples for downstream analysis - Abstract May 11, 2012

Page 1296 of 1437